FDA Inspection 1047746 — Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. — FEI 3002783962

The FDA completed an inspection of Pacira Pharmaceuticals, Inc. on March 1, 2018 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 1, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)